Application
Western blot analysis of ATIC.| Product Name | ATIC antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Mouse monoclonal antibody [F38 P7 H9] to ATICThis gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA-ribosiduria. [provided by RefSeq, Sep 2009] |
| Immunogen | Synthetic peptide, conjugated to Ovalbumin, corresponding to residues A(583) H T N L R L F H H(592) of human ATIC. |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG1 |
| Clone Number | F38 P7 H9 |
| Host Species | Mouse |
| Tested Applications | FACSICC/IFIHC-PWB |
| IHC-P: 5 ug/mL: |
|
| Species Reactivity | HumanMouseDrosophilaRatXenopus |
| Concentration | 1mg/ml (Please refer to the vial label for the specific concentration) |
| Purification | Protein G |
| Gene Synonyms | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase PURH IMPCHASE AICARFT AICAR |
|---|---|
| Target | ATIC |
Application
Western blot analysis of ATIC.| Application Notes | IHC-P: 5 ug/mL: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | -20° C, Avoid Freeze/Thaw Cycles |
| Storage Buffer | PBS containing 0.05 % sodium azide and 1 mg/ml BSA |
